Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Candel Therapeutics (CADL) Cash from Financing Activities: 2020-2024

Historic Cash from Financing Activities for Candel Therapeutics (CADL) over the last 5 years, with Dec 2024 value amounting to $94.3 million.

  • Candel Therapeutics' Cash from Financing Activities fell 436.11% to -$121,000 in Q4 2023 from the same period last year, while for Dec 2023 it was $19.9 million, marking a year-over-year decrease of 78.26%. This contributed to the annual value of $94.3 million for FY2024, which is 78017.36% up from last year.
  • As of FY2024, Candel Therapeutics' Cash from Financing Activities stood at $94.3 million, which was up 78,017.36% from -$121,000 recorded in FY2023.
  • Candel Therapeutics' Cash from Financing Activities' 5-year high stood at $94.3 million during FY2024, with a 5-year trough of -$121,000 in FY2023.
  • For the 3-year period, Candel Therapeutics' Cash from Financing Activities averaged around $38.0 million, with its median value being $20.0 million (2022).
  • Per our database at Business Quant, Candel Therapeutics' Cash from Financing Activities slumped by 100.61% in 2023 and then soared by 78,017.36% in 2024.
  • Over the past 5 years, Candel Therapeutics' Cash from Financing Activities (Yearly) stood at $490,000 in 2020, then surged by 14,553.06% to $71.8 million in 2021, then slumped by 72.18% to $20.0 million in 2022, then plummeted by 100.61% to -$121,000 in 2023, then spiked by 78,017.36% to $94.3 million in 2024.